source
- Manufacturing hurdles grow as next-gen protein therapeutics gain tractionCytiva's sponsored piece highlights growing interest in next-generation protein-based drugs such as antibody-drug conjugates, multispecific antibodies, fragments and synthetic peptides. These moda…
- Lycia Therapeutics raises $317.5 million in upsized Nasdaq IPO as Windward Bio eyes listingLycia Therapeutics completed an initial public offering on Nasdaq, selling shares that generated roughly $317.5 million after the offering was upsized. The company’s debut on the exchange marks a…